Diffuse Lewy body disease: Correlative neuropathology using anti-ubiquitin immunocytochemistry

185Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Diffuse Lewy body disease is an important pathological substrate of the common syndrome of parkinsonian dementia. The new technique of anti-ubiquitin immunocytochemistry has been used in a correlative quantitative neuropathological study of fifteen cases of diffuse Lewy body disease, showing that the severity of dementia is related to cortical Lewy body density, whilst subcortical abnormalities make a much less significant contribution. Cortical senile plaques also appear to be part of the pathology of diffuse Lewy body disease and should not therefore be used as an isolated diagnostic criterion for Alzheimer's disease. Diagnostic criteria for diffuse Lewy body disease are discussed.

Cite

CITATION STYLE

APA

Lennox, G., Lowe, J., Landon, M., Byrne, E. J., Mayer, R. J., & Godwin-Austen, R. B. (1989). Diffuse Lewy body disease: Correlative neuropathology using anti-ubiquitin immunocytochemistry. Journal of Neurology Neurosurgery and Psychiatry, 52(11), 1236–1247. https://doi.org/10.1136/jnnp.52.11.1236

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free